Value-Based Care

Physicians are being warned about indemnification clauses in contracts that can shift immense liability. Here's what doctors need to know to avoid financial ruin.

New long-term data for UPLIZNA and TAVNEOS show sustained disease control and reduced steroid use, offering a tangible difference for rare disease patients.

Insulet's latest Omnipod 5 enhancements are more than a software update; they're a strategic move in the diabetes tech race. Here's what it means.

Freshly independent, MiniMed reports record sales and a robust product pipeline, signaling a focused strategy to dominate the competitive diabetes tech market.

With CE Mark approval for its SOUND REACH Swift, Genesis MedTech brings a 'plug-and-play' ultrasonic shear to Europe, promising to simplify complex open surgeries.

A renowned patient safety expert returns to helm Alberta's quality watchdog, bringing a 'Just Culture' philosophy to a health system in crisis and transition.

A Tulsa jury found a doctor negligent, awarding $15M to a girl left with severe brain damage after a missed diagnosis of bacterial meningitis as an infant.

With backing from GV and Dexcom, Signos is using AI and OTC glucose monitors to offer a new path for sustainable weight management beyond GLP-1 drugs.

New preclinical data shows RTY-406 could be a first-in-class therapy for PSC, a progressive liver disease with no effective treatments.

Free skin cancer screenings in Ottawa highlight a national health crisis as wait times soar and experts demand urgent government action on specialist care.

Wellness brand Le-Vel is launching a telehealth service for prescription peptides, blurring the lines between direct sales and mainstream medicine.

Vanda Pharmaceuticals' rare disease drug gets a key designation in Japan, unlocking major incentives and promising a new treatment for a severe skin disease.

A Canadian pilot's daring evacuation in the DRC highlights a new Ebola crisis, as a rare, untreatable strain spreads through the conflict-ridden region.

John Theurer Cancer Center presents breakthroughs in CAR-T, ADCs, and health equity at ASCO, offering new hope for patients worldwide.

As fatal opioid overdoses triple, a new mobile treatment clinic arrives in Ellensburg, offering a crucial lifeline and eliminating a major barrier to care.

Village Medical Arizona and others are now Bookmark Medical. Discover the strategy behind this national rebranding and its impact on patient care.

Ionetix wins FDA approval for its generic prostate cancer imaging agent, a move set to boost access and shake up the competitive radiopharmaceutical market.

Triage Cancer and Bright Spot Network launch a free national program offering legal, financial, and emotional support to families facing a parent's illness.

ValGenesis's upcoming event explores AI's pivotal role in pharma validation, charting a course from digital systems to intelligent, compliant operations.

A new analysis reveals most insured Americans can't access obesity drugs, even with coverage, due to restrictive insurance hurdles.